Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration.
Pharmaceuticals (Basel). 2023 Jan 16;16(1):132. doi: 10.3390/ph16010132.
Pharmaceuticals (Basel). 2023.
PMID: 36678630
Free PMC article.